Certara, Inc. launches an IPO.

An IPO of Certara, Inc. will take place on December 10, 2020. Certara is a company that provides a biosimulation software. Biosimulation is a powerful technology that is used to conduct virtual trials using virtual patients to predict how drugs behave in different individuals. Biopharmaceutical company use Certara's propietary biosimulation software throughout the whole discovery and development process to make critical decisions that not only save time and money significantly, but also improve drug safety and efficiency, improving lives of millions of people every year.
The current market for solutions provided by Certara is about $10 billion and is expected to grow with an annual average growth rate from 12 to 15 % per year over the next five to seven years.
The listed bookrunners of the IPO are Jefferies, Morgan Stanley, BofA Securities, Credit Suisse, Barclays and William Blair.